Clinical

Dataset Information

0

An observational study of screening sensitive drugs for advanced colorectal cancer based on organoid culture technology

ABSTRACT: Interventions: Case series:None Primary outcome(s): Drug susceptibility;Overall response rate Study Design: Single arm

DISEASE(S): Advanced Colorectal Cancer

PROVIDER: 2739513 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Clinical The recurrence of colorectal adenoma of young patients in Shenzhen: Prospective Observational Study
| 2681212 | ecrin-mdr-crc
Clinical KNBP based MRD monitoring of resectable stage II-IV colorectal cancer and its correlation with prognosis
| 81452 | ecrin-mdr-crc
Clinical The relationship between the completeness of treatment decisions following national guidelines and long-term outcomes in colorectal cancer patients: a study based on the DACCA database
| 79813 | ecrin-mdr-crc
Clinical A prospective observational study evaluating intestinal microbiome as a biomarker to predict the efficacy and toxicity of prostate cancer patients receiveing PARP inhibitors alone or combined with novel ADT agents
| 2707329 | ecrin-mdr-crc
Clinical Medical records based study for correlation between preoperative anemia and postoperative complications and prognosis in patients with colorectal cancer
| 2725782 | ecrin-mdr-crc
Clinical Application of non-invasive multi-omics detection technology based on machine learning in early diagnosis of colorectal lateral developmental tumors
| 87791 | ecrin-mdr-crc
Clinical An open, non-interventional study based on the drug sensitivity detection technology of tumor patient-derived organoids
| 2734714 | ecrin-mdr-crc
Unknown Applications of organoid technology to brain tumors.
| S-EPMC10493676 | biostudies-literature
Clinical Clinical Study for Drug Sensitivity Prediction of Postoperative Adjuvant Chemotherapy for Colorectal cancer by Patient-Derived Organoid Model
| 2689769 | ecrin-mdr-crc
Clinical Screening of specific intestinal flora and establishment of model in patients with immunotherapy sensitive cholangiocarcinoma and pancreatic tumor
| 83665 | ecrin-mdr-crc